Editorial commentary: Is it still important to evaluate patients with ischemic cardiomyopathy for viable dysfunctional myocardium prior to myocardial revascularization?

[1]  R. L. Carter,et al.  Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality , 2017, Circulation. Cardiovascular imaging.

[2]  L. Shaw,et al.  Can Functional Testing for Ischemia and Viability Guide Revascularization? , 2017, JACC. Cardiovascular imaging.

[3]  J. Rouleau,et al.  Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure) , 2016, Circulation.

[4]  J. Rouleau,et al.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. , 2016, The New England journal of medicine.

[5]  Gen Suzuki,et al.  Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. , 2015, Journal of the American College of Cardiology.

[6]  A. Curtis,et al.  Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. , 2014, Journal of the American College of Cardiology.

[7]  I. Piña,et al.  The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. , 2013, JACC. Heart failure.

[8]  D. Berman,et al.  Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.

[9]  J. Canty,et al.  Hibernating Myocardium: Chronically Adapted to Ischemia but Vulnerable to Sudden Death , 2004, Circulation research.

[10]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[11]  G. Heusch,et al.  Hibernating myocardium , 2000, Heart.

[12]  J. Canty,et al.  Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. , 1999, Circulation.

[13]  J. Canty,et al.  Differential 18F-2-deoxyglucose uptake in viable dysfunctional myocardium with normal resting perfusion: evidence for chronic stunning in pigs. , 1999, Circulation.

[14]  J. Canty,et al.  18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium. , 1997, Circulation.

[15]  B. Brent,et al.  Coronary artery bypass surgery in patients with left ventricular dysfunction. , 1986, The American journal of medicine.

[16]  K. Williams,et al.  Myocardial viability-State of the art: Is it still relevant and how to best assess it with imaging? , 2018, Trends in cardiovascular medicine.